Diagnostics and Data Analytics Drive Healthcare Value
Precision Medicine Infrastructure
Healthcare is moving from being population based to the data-informed era of Precision Medicine. Alva10 is enabling this transition through the development, commercialization, and acceleration of diagnostics and data in healthcare.
Employers & Payers
Identify high-cost spending trends and deploy targeted diagnostics to reduce total cost of care and increase employee productivity.
Navigate the path from innovation to coverage with a clear, evidence-driven commercialization strategy and early market access.
Diagnostic Developers & Labs
Understand capital requirements and evidence benchmarks needed for market success in the precision diagnostics space.
Investors
"
"We are using the smartest drugs on the planet in the worst possible way- trial and error." — Craig Leonardi, MD, Dermatologist
The Power of Diagnostics
Right diagnosis. Right treatment. Right time.
Diagnostics are the foundation of Precision Medicine — yet they remain chronically underutilized and underfunded. Alva10 is changing that by placing diagnostics at the forefront of care decisions.
Accurate Disease Screening
Appropriate screening changes patient trajectories and reduces downstream costs dramatically. Alva10 identifies and commercializes screening tools that detect disease earlier, enabling earlier interventions with better outcomes and lower total cost of care.
Risk Assessment
Using data-based risk assessment tool paired with the right diagnostics to assess individual patient risk enables optimized screening, earlier diagnosis, and prevention. Alva10 partners with diagnostic developers to bring validated risk stratification tools to payers and providers.
Primary Diagnosis
Accurate primary diagnosis is the critical first step in effective treatment. Alva10 ensures the right diagnostic tools are available, covered, and used to establish correct diagnoses before costly interventions begin — eliminating misdiagnosis and wasted spend.
How We Partner
One ecosystem. Every stakeholder aligned.
Alva10 works across the precision medicine value chain — from employers managing workforce health costs to the diagnostic companies developing the tools that change patient outcomes. Our model aligns incentives for every party, ensuring diagnostics reach the patients who need them.
EMPLOYERS
Analyze workforce health spending trends. Identify cost drivers based on lack of risk assessment, screening, response prediction are driving costs. Implement targeted diagnostics to reduce total cost of care and improve employee productivity and wellbeing.
Explore employer solutions →
PAYERS
Source diagnostic tools to address your population's greatest clinical and economic challenges. Align coverage decisions with evidence from day one.
Explore payer solutions →
DIAGNOSTIC DEVELOPERS & LABS
Build the clinical and economic evidence required for coverage. Generate data in early market pilot studies. Navigate reimbursement with a clear, payer-aligned strategy.
Explore employer solutions →
INVESTORS
Understand capital requirements, evidence benchmarks, and the metrics that define market success in precision diagnostics.
Explore investor resources →
For Employers
Use healthcare as a strategy for healthier, more productive teams
Employers bear the fiduciary risk and a growing share of healthcare costs with limited visibility into the clinical drivers of that cost. Alva10 uses data analytics to identify drivers of healthcare spending in your workforce population and deploys targeted solutions that reduce total cost of care and improve employee productivity.
Spending Trend Analysis
We analyze your claims data to surface high-cost patterns and pinpoint where missed primary diagnoses, unscreened risk, of lack of tools to predict response are driving spend.
Targeted Diagnostic Deployment
We identify and implement the right risk assessment and screening tools to catch disease earlier, guide treatment decisions accurately, and reduce total cost of care.
Workforce Productivity Impact
Accurate diagnosis, proper risk assessment and earlier intervention mean fewer treatment side effects, faster recovery, and a healthier, more productive workforce.
For Investors
Clarity on capital, evidence, and the path to market
Investing in precision diagnostics requires understanding a unique set of commercial dynamics — from evidence generation costs to early market opportunities and payer adoption benchmarks. Alva10 provides investors with a structured framework and market intelligence to evaluate and support diagnostic opportunities with confidence..
Capital Requirements
We help define the evidence development costs required for each diagnostic opportunity — from clinical validation through pilot studies and payer submission — so investors understand the full capital timeline.
Evidence Benchmarks
We establish the specific clinical and economic evidence thresholds that payers require for coverage — giving investors clear, defined milestones rather than moving goalposts.
Market Success Metrics
We identify the commercial indicators — market need, clinical drivers, reimbursement rates, adoption benchmarks, payer coverage breadth — that define a successful market entry and underpin ROI projections for each asset.
"
"In no other industry can the payer not give the supplier their vendor requirements." — Pharmacy Director, Health Insurance Company
Our Approach
How Alva10 creates value across the ecosystem
Our model starts with data analytics to understand what the market needs from the perspective of every stakeholder- patient, clinician, health system, payer/employer- so every diagnostic solution we source is built on clinical and economic evidence from day one.
01.
Identify the Gap
We work with employers and payers to analyze population and claims data — surfacing where missed primary diagnoses, unassessed risk, drug switching, poor response rates and screening gaps are driving increasing costs and worse patient outcomes.
02.
Source the Solution
We identify diagnostics tools for primary diagnosis, risk assessment, response prediction, and screening technologies from our precision medicine portfolio, matching each innovation to the clinical and economic challenge.
03.
Drive Coverage & Use
We partner with diagnostic companies to build the evidence required for clinical utilization, employer and pilot study deployment, and employer use and payer coverage— creating a clear, funded path to patients.
Our Approach
How Alva10 creates value across the ecosystem
Our model starts with data analytics to understand what the market needs from the perspective of every stakeholder- patient, clinician, health system, payer/employer- so every diagnostic solution we source is built on clinical and economic evidence from day one.
01.
Identify the Gap
We work with employers and payers to analyze population and claims data — surfacing where missed primary diagnoses, unassessed risk, and screening gaps are driving the highest costs and worst patient outcomes.
02.
Source the Solution
We curate best-in-class primary diagnosis, risk assessment, response prediction, and screening technologies from our precision medicine portfolio, matching each innovation to the specific clinical and economic challenge.
03.
Drive Coverage & Use
We partner with diagnostic companies to build the evidence required for clinical utilization, pilot study deployment, and employer use and payer coverage— creating a clear, funded path to patients.
